ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
Two recently published large clinical trials, NCIC MA.20 and EORTC 22922, raised a lot of interest in and a lot of questions about when radiation helps for treating lymph nodes in breast cancer. The data are more complicated than often presented.
This is the story of how an eager chemistry professor and a well-intended but misguided federal judge transformed cancer care and drug development in Brazil into a convoluted soap opera.
When patients express fears and misgivings in clinic, there is an opportunity to dispel myths, diminish shame, and focus on living a full life despite cancer.
Each year, the ASCO President selects a theme around which the ASCO Annual Meeting coalesces. Dr. Julie M. Vose’s theme, as you will see in our cover story, highlights the...
In what is the first (and hopefully one of many) example of using modern genomic methods to match treatments to the molecular defects in prostate cancer, the U.S. FDA has just granted “breakthrough designation” to olaparib.
The American Board of Internal Medicine (ABIM) invited all ABIM-certified physicians to participate in a review of the blueprints that outline content areas for subspecialty Maintenance of Certification (MOC) exams.
Most times, I feel excited to be an oncologist. Oncology research is accelerating and every week brings more news, whether it be a deeper understanding of tumor genomics, a broader understanding of cancer genetics and risk, and, it seems, more ways to provide precision therapy. Studies are coming...
During 2 weeks of challenging inpatient hospital service, I made it my goal to give my residents the best possible exposure to our field, and to allow them as much autonomy as possible.
ASCO CEO Dr. Allen S. Lichter reflects on an optimistic approach to the challenges of providing high-quality cancer care around the globe on World Cancer Day.
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in the public health system are bleak in the short term.
There are so many myths about cancers and their causation that may be detrimental to cancer control efforts, especially in sub-Saharan Africa, Dr.Fredrick Chite Asirwa explains.
When a group of medical students approached Dr. Frederick Chite Asirwa to help lead their efforts towards cancer awareness in various schools in Western Kenya, he gladly agreed.
Dr. Julie Gralow is excited to be participating in Union for International Cancer Control World Cancer Day events along with more than 500 Nigerian patients, survivor advocates, health care providers, government officials, students, and parents.
Prevention is better than cure—an age-old saying, but one that is highly relevant in these times of increasing incidence of diseases and skyrocketing health care costs, notes Dr. Monica Malik.
Dr. Edward L. Trimble discusses working together across regions and across borders to promote cancer prevention and cancer control, and making a personal commitment to bringing an end to cancer.
Blogs
ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
No Results.
Pages
Advertisement